Sr Manager, Finance - Accounting at Gilead Sciences

Cork, County Cork, Ireland

Gilead Sciences Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • In-depth knowledge of general accounting policies and procedures and GAAP
  • In-depth knowledge of local statutory and tax reporting requirements
  • In-depth knowledge of JD Edwards or equivalent is essential
  • Proficiency with Microsoft tools (Excel, Outlook, and Word)
  • Proficient in all aspects of accounting and finance
  • Ability to successfully manage the work of financial personnel and interact effectively with non-financial personnel
  • Strong presentation skills
  • Significant experience in a multi-currency environment
  • Ability to work in a deadline-driven and multi-tasking environment
  • 8+ years of relevant experience and BA or BS degree in accounting or equivalent
  • Previous supervisory experience
  • CPA qualification is preferred
  • CMA qualification is preferred
  • An MBA is preferred
  • Experience in biotech or pharmaceuticals industry a plus
  • Experience in multi-national organization a plus

Responsibilities

  • Provides direction and coordination to professional and clerical staff within the department and cross-functionally
  • Responsible for the timely and accurate review and posting of month end close and accounting transactions; P&L and balance sheet account analysis, review, reconciliation & resolution; and financial analysis
  • Ensures financial records are in compliance with GAAP
  • Consistently maintains appropriate internal controls and upholds company policies & procedures including Worldwide Controller’s manual
  • Interacts successfully with internal and external auditors and supports quarter end, interim and year-end audits by providing timely & accurate data and communication
  • Evaluates processes and recommends & implements process improvements

Skills

GAAP
JD Edwards
Microsoft Excel
Microsoft Outlook
Microsoft Word
multi-currency accounting
statutory reporting
tax reporting
CPA
supervisory experience

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI